Pantofir (Pantoprazole)

Pantoprazole, the active ingredient in Pantofir, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and Zollinger‑Ellison syndrome in adults. GNH USA supplies Pantofir as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton pump inhibitor that acts on the acid‑secretion pathway of the stomach. It is indicated for several gastrointestinal conditions: - Gastro‑oesophageal reflux disease (GERD): Improves healing of erosive esophagitis and relieves heartburn. - Erosive esophagitis: Promotes healing of erosions in the oesophageal lining. - Zollinger‑Ellison syndrome: Controls excessive gastric acid production associated with this rare tumour. - Prevention of NSAID‑induced ulcers: Reduces the risk of ulcer development in patients taking non‑steroidal anti‑inflammatory drugs.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually transient. - Nausea: occasional mild upset. - Abdominal pain: mild cramping. - Flatulence: increased gas. - Constipation: occasional bowel habit change.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): skin rash, swelling, difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhoea. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Fracture risk: reduced bone mineral density with long‑term use. - Liver enzyme elevation: increased ALT/AST. - Acute interstitial nephritis: kidney inflammation.

When prescribing Pantoprazole, clinicians should consider several safety aspects: - Assess patient history for liver disease or renal impairment. - Monitor electrolyte levels, especially magnesium, during prolonged therapy. - Evaluate risk of osteoporosis in patients on long‑term therapy. - Use caution in pregnancy and breast‑feeding if benefits outweigh risks. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazole may interact with several medicines that share metabolic pathways or affect gastric pH.

Major Interactions (Avoid): - Ketoconazole oral: reduced absorption due to higher gastric pH. - Atazanavir oral: markedly decreased plasma levels. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of INR values. - Methotrex A . - Phenytoin: possible C .